About this Research Topic
The state of the art and research perspectives of pathology and pathobiology of pulmonary hypertension were published in 2019 by prominent experts in the field. One of the most exciting challenges is translating pre-clinical findings to clinical studies for a rare disease like PH. Because animal models do not recapitulate the full spectrum of human disease, it is of great interest to use human samples like tissues from explanted lungs or blood samples. In order to provide individualized therapies, rigorous phenotyping, endotyping and genotyping are essential. Biomarkers that guide diagnosis, therapeutic decisions and prognosis would be ideal tools to achieve better patient care.
Dysfunction of the pulmonary endothelium, abnormal accumulation of smooth muscle cells and adventitial fibroblast as well as dysregulation of the immune system, are pathophysiological processes on a cellular level in PH that warrant further investigation. On a molecular level, ion channel abnormalities, transcription signaling dysregulations, epigenetic disturbances and metabolic changes are the most promising topics with translational potential. We seek high-quality papers that would fill the gap between bench and bedside. Original articles that include well-characterized real-world patient collectives are desired.
We want to ask contributors to submit papers that address the following themes:
- translational approach for new molecules targeting PH pathways
- translational approach for repurposed molecules targeting PH pathways
- new treatment options for PH groups II, III, V
- biomarkers of diagnosis for a particular type of PH
- biomarkers that distinguish "responders" from "non-responders" to targeted PH therapies
Keywords: pulmonary vascular physiology, pulmonary arterial hypertension, chronic thromboembolic pulmonary hypertension, biomarker, blood derived biomarker, targeted PAH therapy, personalized medicine, metabolomics, proteomics, transcriptomics, genetics of pulmonary hypertension, genomics, interstitial lung disease, biomarkers, pulmonary circulation, pulmonary hemodynamics, non invasive diagnostics, chest imaging, World Symposium on Pulmonary Hypertension, pathology of pulmonary hypertension, prognosis, screening, translational approach
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.